Clinical Studies

  • electroCore is presently running the largest clinical trial program in the world…
  • read more

News & Events

  • Study in intl. headache journal finds non-invasive vagus nerve stimulation effective…
  • read more

Pipeline

  • electroCore is researching a wide range of medical conditions which may respond to nVNS…
  • read more

Quote

"We are always searching for acute and preventive treatments that are effective without adverse events. The field of neuromodulation in general, and non-invasive vagal nerve stimulation (nVNS) in particular, could bring us powerful new treatment options for people suffering from severe headaches without the side effects patients have previously had to tolerate. The data expected later this year on nVNS will hopefully expand the use of this novel, non-medicinal treatment."

Alan Rapoport, MD
Clinical Professor of Neurology
The David Geffen School of Medicine at UCLA in Los Angeles

President, The International Headache Society (IHS)



Sign up for more…

E-Mail :

Enter this code and then hit Submit (this helps eliminate spam):
captcha

In The News

 

You are leaving the gammaCore
product section.

This site contains some product information that has not been reviewed by the FDA and the devices are not currently marketed in the United States. The information on this site is not country-specific. Not all products or indications for use are approved in all countries within the global market. Please contact your local ElectroCore representative and/or the distributor web page for the latest information specific to your country.

By clicking the "Yes, proceed" button below, you are acknowledging this disclaimer. Otherwise, click "No, exit":